Prospective Geometric Analysis of Ultra-Widefield OCTA Characteristics in Central Serous Chorioretinopathy Patients
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-60
SponsorSun Yat-sen University
About this trial
By leveraging parameters including fractal dimension and topological index, we constructed a quantitative evaluation framework for ultra-widefield optical coherence tomography angiography (UWF-OCTA) images in patients with central serous chorioretinopathy (CSC), thus overcoming the limitations of conventional qualitative analysis.
Eligibility criteria
Qualifiers
Adults aged 18 to 60 years, inclusive;
Clinical diagnosis of central serous chorioretinopathy (CSC);
Completion of fundus fluorescein angiography (FFA) and indocyanine green angiography (ICGA) examinations;
Completion of ultra-widefield optical coherence tomography angiography (UWF-OCTA) imaging;
Disqualifiers
Presence of systemic diseases that may affect study outcomes or participant safety;
Pregnant or lactating women;
History of psychiatric or mental disorders that may impair compliance;
Hemorrhagic diathesis or requirement for long-term anticoagulant therapy;
Trial design
Treatments tested in this trial
- Not listed
Trial groups
120 Participants
are grouped into 4 trial groupsSponsors and collaborators
Source ClinicalTrials.gov